BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer

BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer

BONESUPPORT, a manufacturer of injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or relatedsurgery, has announced the appointment of Michael Diefenbeck, pictured, as Chief Medical Officer.

Dr Diefenbeck founded Scientific Consulting in Orthopaedic Surgery in 2014 and has worked for BONESUPPORT on a range of clinical projects related to CERAMENT™ as an independent clinical advisor.

He is currently honorary consultant at Nuffield Orthopaedic Centre, Oxford University Hospitals. Diefenbeck studied medicine at Munich and was trained as an orthopaedic surgeon, specialising in trauma care and bone infections. He has 14 years’ clinical experience at different German hospitals (BG Unfallklinik Murnau, BG Kliniken Bergmannstrost Halle/Saale, University Hospital Jena and Schön Klinik Hamburg Eilbek). At University Hospital Jena he finished his PhD in 2011 and has since been involved in surgical education and training programs for students. He is author of 24 Pub-med listed research articles.

Dr Diefenbeck said: “I am excited to be joining BONESUPPORT at a particularly exciting time for the company. I look forward to working with the BONESUPPORT team, to help shape the future development of the company as it continues to develop and reinforce the clinical benefits that its CERAMENT based products deliver.”

Categories: COMPANY NEWS

Write a Comment

Your e-mail address will not be published.
Required fields are marked*